GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 98 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $23,000 | +64.3% | 1,000 | 0.0% | 0.00% | – |
Q4 2020 | $14,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $14,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $14,000 | +75.0% | 1,000 | -50.0% | 0.00% | – |
Q1 2020 | $8,000 | -11.1% | 2,000 | 0.0% | 0.00% | – |
Q4 2019 | $9,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2019 | $12,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2019 | $12,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
Q1 2019 | $14,000 | +55.6% | 2,000 | 0.0% | 0.00% | – |
Q4 2018 | $9,000 | -35.7% | 2,000 | 0.0% | 0.00% | – |
Q3 2018 | $14,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
Q2 2018 | $12,000 | +20.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2018 | $10,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |